Ethyl glucuronide is a minor metabolite of ethanol, and its presence in urine can be used as a laboratory test to detect recent alcohol intake, even for some time after the ethanol is no longer measurable. A simple analytical procedure was developed based on direct injection of urine diluted with a deuterated internal standard into an electrospray liquid chromatographic-mass spectrometric (LC-MS) system. A novel LC system using a porous graphite column (Hypercarb) enabled an isocratic elution with retention times of 5-6 minutes. The intra- and inter-assay coefficients of variation were 2-12%, and the measuring range was 0.1-1,500 mg/L (0.45-6,750 micromol/L). Ethyl glucuronide was found to be stable in urine for more than 4 days at room temperature, and no artifactual formation was observed on storage of urine samples fortified with 1% ethanol. Ethyl glucuronide was not detected in urine samples collected after abstinence from alcohol. Intake of a very low amount (7 g) of ethanol produced ethyl glucuronide values up to 8.4 mg/L after 4 hours and was still detectable at 6 hours. When the method was applied for routine screening of 252 clinical urine samples (range, 0-1,240 mg/L), it fulfilled the need for a simple and reliable assay to be used in the evaluation of urinary ethyl glucuronide as a routine test of recent alcohol intake.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/00007691-200210000-00011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A randomized controlled trial to assess whether a telehealth-based contingency management intervention reduces alcohol use for individuals with alcohol use disorder.
Contemp Clin Trials
January 2025
Department of Community and Behavioral Health, Elson S. Floyd College of Medicine, Washington State University, Spokane, WA, United States of America.
Background: Contingency management (CM) is an intervention for alcohol use disorder (AUD) that reinforces abstinence, as confirmed by alcohol biomarkers. CM is usually brief (12-16 weeks) despite evidence that longer interventions have better long-term outcomes. Most CM models are in-person which can also be a barrier for treatment.
View Article and Find Full Text PDFApplication of LC-MS/MS for the Identification of Drugs of Abuse in Driver's License Regranting Procedures.
Pharmaceuticals (Basel)
December 2024
Laboratory of Forensic Toxicology, Section of Legal Medicine, Social Security and Forensic Toxicology, Department of Biomedicine and Prevention, Faculty of Medicine and Surgery, University of Rome "Tor Vergata", Via Montpellier 1, 00133 Rome, Italy.
Drugged driving is associated with an increased risk of road accidents worldwide. In Italy, driving under the influence (DUI) of alcohol and drugs is a reason for driving disqualification or revocation of the driving license. Drivers charged with driving under the influence of alcohol and drugs must attend a Local Medical Commission (LMC) to undergo mandatory examinations to regain the suspended license.
View Article and Find Full Text PDFThe Prevalence and Changes in Alcohol Consumption across Three Trimesters of Pregnancy Assessed by Ethyl Glucuronide Concentration in Maternal Hair and Self-Reports: A Cross-Sectional Study.
Eur Addict Res
November 2024
National Centre on Addiction and Doping, Istituto Superiore di Sanità, Rome, Italy.
Introduction: The teratogenic effect of alcohol is well known, but its prevalence is usually underestimated. This study presents the findings of a cross-sectional study conducted in Poland, which aimed to assess the prevalence and changes in alcohol consumption during pregnancy. The study utilized ethyl glucuronide (EtG) concentration in maternal hair and self-reports as measures to evaluate alcohol intake across the three trimesters of pregnancy.
View Article and Find Full Text PDFUtilization of biomarkers for alcohol use in candidates for liver transplantation with alcohol-associated liver disease.
Liver Transpl
November 2024
Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.
Article Synopsis
- Many liver transplantation programs no longer require a set period of abstinence for candidates, but effective monitoring for ongoing alcohol use is necessary.
- Urinary ethyl glucuronide (EtG) testing is highlighted as an objective measure to detect alcohol consumption in patients with alcohol-associated liver disease (ALD) during the pretransplant phase.
- In a study of 497 ALD patients, only 8% tested positive for EtG, with severe alcohol use disorder, lower daily consumption, and prolonged substance use being significant factors linked to positive results; psychiatric issues were not strongly related.
Italian Guidelines for the diagnosis and treatment of Fetal Alcohol Spectrum Disorders: detecting alcohol drinking during pregnancy.
Riv Psichiatr
October 2024
Institute of Biochemistry and Cell Biology (IBBC-CNR), Department of Sensory Organs, Sapienza University of Rome, Italy.
Article Synopsis
- - Fetal Alcohol Spectrum Disorders (FASD) refers to a variety of conditions caused by drinking alcohol during pregnancy, impacting the central nervous system, growth, and facial features.
- - Early screening for FASD is critical since there are no treatments; methods include assessing alcohol biomarkers in maternal blood and meconium, as well as using sensitive questionnaires to identify at-risk pregnancies.
- - The review emphasizes the importance of combining alcohol biomarkers with traditional screening tools to ensure more accurate detection and monitoring of alcohol consumption during pregnancy.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!